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INTRODUCTION:
The specific aims outlined in this proposal seek to address the importance of neuropilin-1 (NP 1) in breast cancer progression. Importantly, our group has characterized a novel autocrine survival pathway in breast carcinoma cells specifically mediated by binding of vascular endothelial growth factor (VEGF) to NP 11. These studies were the first to identify a functional role for NP1 in tumor cells and they led us to hypothesize that NP1 plays a critical role in breast cancer metastasis. To further investigate the role of NP1 in breast cancer progression, we proposed to evaluate the expression of NP1 as a function of tumor grade, to determine the contribution of NP1 in tumor formation and metastasis, and to assess the importance of the NP1 cytoplasmic domain in downstream signaling events. The results of these experiments will determine whether NP1 is a critical mediator in the progression of metastatic breast cancer.
BODY: Specific Aim #1: Investigate the expression of NP1 as a function of breast cancer progression. Summary: Because NP1 is expressed in highly aggressive and metastatic but not in less aggressive and non-metastatic breast carcinoma cell lines 2 , we wanted to investigate the expression of NP1 in human tumors as a function of breast cancer progression. In collaboration with Dr. Larry Brown, a clinical pathologist at BIDMC, we performed in situ hybridization experiments on greater than ten human cases at varying disease stages. We found that NP1 was expressed at a low level in tumor cells but that the level of NP1 expression did not increase with disease progression (data not shown). In addition, we found that NP1 was ubiquitously expressed at a high level in endothelial cells and fibroblasts. Although the expression of NP1 by endothelial cells was anticipated 2 , the presence of NP1 in fibroblasts was a novel finding. Interestingly, the expression ofNP I was recently reported in prostatic stromal cells corroborating our finding that NP1 is present in fibroblasts 3 . To date, we have been unable to confirm at the protein level the expression profile of NP1 in breast tumor progression or the expression of NP1 on stromal fibroblasts due to the lack of suitable antibodies to detect NPI in paraformaldehyde-fixed human breast tissues. However, the future use of frozen tissue specimens to detect NP 1 protein, as was recently reported in a study of colon adenocarcinomas, may overcome this limitation 4 .
Specific Aim #2: Demonstrate that NP1 is sufficient and necessary for the progression of tumorigenic breast carcinoma cells to the metastatic phenotype. Summary: To explore the significance of NP1 on metastasis in vivo, we generated MDA-MB-231 and SUM-159 breast carcinoma cell lines that retrovirally expressed shRNA oligonucleotides specific to NP1 or control scrambled-sequence oligonucleotides. We found that we were unable to generate NPl-deficient cell lines using this RNA interference (RNAi) strategy even though the selected oligonucleotide sequence was efficient at reducing NP1 expression in transient transfection experiments. Consistent with its role as a pro-survival gene 1 , we concluded that NP1 is essential to the survival of these cells and that cells with stably decreased NP1 expression likely do not survive the selection process but instead undergo apoptosis. To circumvent this problem and to investigate the importance ofNP I in metastasis, a conditional system for shRNA expression will need to be generated for use in future studies.
Final Report 2005 Elizabeth Lipscomb We initially attempted to stably reduce NP 1 expression in the MDA-MB-231 breast carcinoma cell line. Because this approach was unsuccessful and to ensure that this phenomenon was not cell line specific, we next tried to decrease NP1 expression in the highly invasive SUM-159 breast carcinoma cell line 5 ' 6 . Although this endeavor also failed to generate a NP1-deficient breast carcinoma cell line, we have found the SUM-159 cell line to be an excellent model system for investigating signaling pathways in vitro as well as for studying tumor formation and metastasis in vivo. Given that we have shown that the i6P34 integrin regulates VEGF translation and that NP1 mediates tumor cell survival in a VEGFdependent manner 1 ' 7 , we generated a SUM-159 cell line that lacks expression of the x6134 integrin using shRNA retroviral strategies ( Figure 1 ). The data generated with this x6134-deficient cell line are summarized below. immunoblotted for 34 and 13-actin. Table 1 . Expression of the cL61M integrin is necessary for tumor formation in vivo. Scr-, 134-RNAi, and 34-RNAi+134 SUM-159 cells (2 x 106 cells/injection) were injected into the mammary fat pad of immunocompromised mice. After 7-10 weeks, the frequency of tumor formation was reduced in mice injected with P34-RNAi cells by 48% and 24% compared to Scr-RNAi and P4-RNAi+p34 cells, respectively. The mean tumor weight in grams (g, +/-SEM) of the four mice bearing P4-RNAi tumors was significantly less than the average weight of the Scr-RNAi tumors (two-tailed t test, p < 0.005), whereas the 134-RNAi+134 tumors were comparable in weight to the Scr-RNAi tumors. Figure 2 . Increased apoptosis and decreased VEGF in mammary tumors formed in 0M-RNAi injected mice. Assessment of the level of cell death (panels a-c) occurring in the mammary tumors that formed following orthotopic injection of the Scr-RNAi (a), P34-RNAi (b) and P34-RNAi+p4 (c) cell lines was determined by TUNEL labeling. The red-brown staining is indicative of apoptosis and is dramatically enhanced in the tumor formed following injection of the P4-RNAi cell line (b) compared to the Scr-RNAi and 34-RNAi+p4 cell lines (a and c, respectively). VEGF immunohistochemistry (panels d-f) performed on tumors resulting from injection of Scr-RNAi (d), 034-RNAi (e) and P34-RNAi+p4 (f) cell lines revealed a much higher level of VEGF expression in the Scr-RNAi (d) and 134-RNAi+f34 (f) tumors compared to the P34-RNAi (e) tumor.
Specific Aim #3: Define the downstream signaling events mediated by NP1 that are responsible for metastasis. Summary: Our group has previously demonstrated that expression of NP1 in a non-NP1 expressing breast carcinoma cell line (MDA-MB-453 cells) is sufficient to promote survival of these cells in hypoxic conditions (5% CO 2 , 3% 02, 92 % N 2 ) 1 . To investigate the involvement of the NP1 cytoplasmic-domain in this survival, MDA-MB-453 cells were transfected with full-length NP1, truncated NP1, or a control empty vector. After 72 hours in serum-free and hypoxic conditions, full-length NP1 decreased the level of apoptosis by 30% compared to cells transfected with a control empty vector. Unfortunately, the level of cell death was comparable for cells transfected with either full-length or truncated NP1. The more recently identified role of NP1 as a chemotaxis inhibitor prompted us to investigate whether the cytoplasmic domain of NP1 is important for its migratory function 8 . In three independent migration assays, the level of migration was comparable for breast carcinoma cells transfected with either full-length or truncated NP1. Taken together, these data suggest that the cytoplasmic domain of NP1 does not play a critical role in either its pro-survival or migration-inhibitor function.
The cytoplasmic domain of NP1 has been shown to interact with GIPC, a PDZ domain-containing protein in olfactory bulb membrane extracts 9 . To address whether this interaction is important in the signaling events mediated by NP1 in breast carcinoma cells, we attempted to co-immunoprecipitate endogenously expressed NP1 and GIPC in MDA-MB-231 cells. Using the same lysis buffer as described by Cai and Reed 9 , we were unable to co-immunoprecipitate NP 1 and GIPC in two separate experiments and we do not currently believe that a NP 1 and GIPC protein-protein interaction exists in breast carcinoma cells. Based on experience and training supported by this award, I have been invited to interview for a position as an independent investigator at five universities and I have been offered two positions. At the present time, I am still considering my options but hope to end my search in the near future and begin my journey as a junior-faculty member in the Fall of 2005.
CONCLUSIONS:
The goal of this proposal was to define the mechanism by which NP1 contributes to the survival and metastasis of breast carcinoma cells. We have determined that the level ofNP1 does not increase in human tumors as a function of breast cancer progression (Aim 1). We have also shown that the cytoplasmic domain of NP1 is not required for its survival function or for its role as a chemotaxis inhibitor (Aim 3). To evaluate the importance of NP1 in tumor formation and metastasis, we attempted to generate NP 1-deficient breast carcinoma cell lines using RNAi (Aim 2). Unfortunately, this approach has been unsuccessful likely because NP1 expression is essential to the survival of these cells. As an alternative approach, we generated a SUM-159 breast carcinoma cell line that lacks expression of the a6j34 integrin using the RNAi strategy and model system initially designed to study NP1 function. Given that the u6P34 integrin regulates VEGF translation and that NP1 mediates tumor cell survival in a VEGF-dependent pathway '7, this approach enabled us to further study the signaling pathways upstream of the NP 1 receptor. We have found that the ca634 integrin regulates the translation of VEGF in a P13-K-and mTOR-dependent pathway (Figure 3) 7. In addition, we have shown that one mechanism by which VEGF promotes tumor cell survival is by activating the NP1 receptor'. Furthermore, we have shown that this oa6p34-mediated expression of VEGF and consequent tumor cell survival promotes tumor formation and growth in vivo. a604 NPl-dependent pathway. Survival Tumor Formation/Growth It has been proposed that a constitutive, physical asAn integrin of particular relevance to invasive carcinoma is sociation of the Met receptor and the a 6 ,3, integrin exists a 6 34 (6) (7) (8) . This integrin, which is expressed primarily on the on the surface of invasive carcinoma cells and that hep-basal surface of most epithelia and in most carcinoma cells, is atocyte growth factor (HGF)-mediated invasion is de-defined as an adhesion receptor for most of the known basependent on a13 4 (Trusolino, L., Bertotti, A., and Como-ment membrane laminins (6, 9) . A primary function of a6/3 4 , glio, P. M. (2001) Cell 107, 643-654). The potential revealed by studies of knock-out mice, is to maintain the integsignificance of these results prompted us to re-examine rity of epithelia (10, 11) . This critical role for a6/ 3 4 derives from this hypothesis. Using three different carcinoma cell its ability to mediate the formation of stable adhesive struclines that express both Met and a 6 13 4 , we were unable to tures, termed hemidesmosomes, on the basal cell surface that detect the constitutive association of these receptors by link the cytokeratin network with laminins in the basement co-immunoprecipitation. Moreover, carcinoma cells membrane (12) . Recent studies have revealed novel and importhat lacked expression of a13 4 exhibited Met-dependent tant functions for this integrin in the migration and invasion of invasion toward HGF, and increasing Met expression by tant ctios for Thi exrinsin th migratio ainvain of viral infection of these cells enhanced invasion without carcinoma cells (13) . The expression of a 6 f3 4 is maintained or vinducingection of ex esecesion.A houghd exprsion ofithout often increased in invasive and metastatic carcinomas, and its inducing U0•4 expression. Although expression Of a6134 in such cells enhanced their invasion to HGF, it also expression level correlates with the progression of these carcienhanced their ability to invade toward other chemoatnomas (14) . More recently, compelling data were reported that tractants such as lysophosphatidic acid, and this latter suggest the a 6 /3 4 integrin is essential for squamous carcinogeninvasion was not inhibited by a function-blocking Met esis (15). antibody. Finally, depletion of /34 by RNA interference in Given the potential importance of the a634 integrin to invainvasive carcinoma cells that express both receptors sive carcinoma, extensive efforts are being made to define the reduced the ability of these cells to invade toward HGF mechanisms by which it facilitates the invasive process. Adby -25%, but it did not abrogate their invasion. These vances include the observation that a6934 is localized to the data argue that the invasive function of Met can be leading edge of migrating carcinoma cells where it can contribindependent of a613 4 and that a 6 /3 4 has a generic influ-ute to the formation and stabilization of actin protrusions (16, ence on the invasion of carcinoma cells that is not spe-17). In addition, there is evidence from several laboratories cific to Met.
indicating that a6/34 stimulates the activity of phosphoinositide 3-OH kinase (P13K)1 in invasive carcinoma cells and that P13K is essential for migration and invasion (7, 18) . Interestingly, it Understanding the receptor-mediated mechanisms that un-has been suggested that 6/34, activates P13K and mediates derlie invasive carcinoma is a timely and significant endeavor, invasion through its ability to cooperate with specific growth The involvement of specific integrins and growth factor recepfactor receptors (1, 4, 18) . For example, a 6 9 4 has been shown to tors in the invasive process is established, and several lines of associate with erb132 on the surface of breast carcinoma cells, evidence indicate that these two classes of surface receptors and this interaction appears to facilitate activation of P13K and may cooperate to effect a wide range of biological functions, invasion (18, 19) . including the migration and invasion of tumor cells (2) (3) (4) . The
More recently, it was argued that a6/34 functions as an esavailable data indicate that integrin and growth factor signalsential adaptor protein for the Met receptor in invasive carciing can be synergistic, and in some cases physical association noma cells (1) . The impact of this finding is amplified by the may occur between these receptor types. Insight into the na-fact that substantial evidence exists for the importance of Met ture of such receptor interactions has important implications in the scattering, invasion, and metastasis of tumor cells (20, not only for understanding the biology of tumor invasion but 21). If a60/34 were an essential, specific adaptor for Met function also for the design and use of therapeutics targeted to these in these events, the consequences for carcinoma biology and receptors (5) .
therapy would be profound. The potential significance of these results prompted us to re-examine the central findings of this study, which were that a selective physical association between * This work was supported by National Institutes of Health Grant Met and 06/34, exists on the surface of invasive carcinoma cells CA80789 (to A. M. M.) and U. S. Army Medical Research Program Grants BC001077 (to J. C.) and BC010115 (to E. A. L.). The costs of and that Met cannot promote invasion in the absence of publication of this article were defrayed in part by the payment of page a6434 expression. charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Cells-MDA-MB-231 and MDA-MB-435 breast carcinoma cells were in TBS-T, the membranes were incubated for 1 h in blocking buffer obtained from the Lombardi Breast Cancer Depository at Georgetown containing horseradish peroxidase-conjugated secondary antibodies. University (Washington, DC), and A431 cells were purchased from After three 10-min washes in TBS-T, proteins were detected by enAmerican Type Culture Collection. Cells were grown in low glucose hanced chemiluminescence (Pierce). Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, For immunoblots involving the phosphotyrosine Ab (anti-phospho-1% penicillin-streptomycin, and 25 mm Hepes. The generation of stable tyrosine, clone PY99, Cell Signaling Technology, Beverly, MA), the transfectants of MDA-MB-435 cells that express the oe`4 integrin has membranes were blocked for 1 h using 10 mm Tris buffer (pH 7.5) been described previously (7) . For Met expression studies, a vesicular containing 0.5 M NaC1, 0.1% Tween 20, and 2% bovine serum albumin stomatitis virus-coated retrovirus containing Met cDNA was obtained (w/v). The membranes were washed briefly and then incubated overfrom Dr. Morag Park (McGill University, Montreal, Quebec, Canada) .
night at 4 'C in the same blocking buffer containing the phosphoty-SUM-159 cells were obtained from Dr. Stephen Ethier at the University rosine Ab. After washing, the filters were incubated for 1 h in blocking of Michigan Comprehensive Cancer Center (Ann Arbor, MI) and mainbuffer containing horseradish peroxidase-conjugated secondary Ab, and tanMed in Ham's F-12 medium containing 5% fetal bovine serum, 5 the proteins were detected by enhanced chemiluminescence. tg/ml insulin, 1 mg/ml hydrocortisol, 1% penicillin-streptomycin, and
Invasion Assays-To prepare the Transwell membranes (Corning 25 u li Hepes (22). Glass) for the invasion assays, 0.5 ug of Matrigel (Collaborative ReTo create 25 siRNA-pSUPER and/34 SCR-pSUPER expression vectsearch, Waltham, MA) was diluted with cold water and left to dry ors, the following oligonucleotides (Invitrogen) were annealed and li-foll ght onto the upper side of the membranes at 25 °C. On the gated into pSUPER (a gift from R. Agami, The Netherlands Cancer following day, the lower sides of the membranes were coated with 10
Institute, Amsterdam, The Netherlands) between the BglII and HindAII tg/ml laminin-1 (Calbiochem) and again left to dry overnight at 4 'C. Institutes: Amsierda, gTcccGetGCraCGGAGbetGTGTttcaagl agnGAThe membranes were blocked with Dulbecco's modified Eagle's medium sites: C 4 siRNA, 5'-gatccccGAGCTGCACGGAGTGTGTCttcaagagaGA-(or Ham's F-12 medium for SUM-159) for 1 h at 37 'C. Cells were CACACTCCGTGCAGCTCtttttggaaa-3' and 5'-agcttttccaaaaaGAGCTtrypsinized on the following day and resuspended in Dulbecco's modiGCACGGAGTGTGTCtctcttgaaGACACACTCCGTGCAGCTCggg-3'; 04 fied Eagle's medium or Ham's F-12 medium containing 0.25% heat-SCR, 5'-gatecccGTTGTCGAGGAACGGTGCCttcaagagaGGCACCGTTinactivated lipid-free bovine serum albumin, and a total of 5 X 10' cells CCTCGACAACtttttggaaa-3' and 5'-agcttttccaaaaaGTTGTCGAGGAAwas added to the upper chamber of each well. Chemoattractants (50 CGGTGCCtctettgaaGGCACCGTTCCTCGACAACggg-3'. EcoRI-and ng/ml HGF (R & D System, Minneapolis, MN), 100 ng/ml lysophosphaXhoI-digested inserts containing the H1-RNA promoter and either P4 tidic acid (Sigma), or 3T3 cell-conditioned medium) were added to the siRNA or 34 SCR targeting oligonucleotides from pSUPER were then bottom wells in Dulbecco's modified Eagle's medium-bovine serum alsubcloned into pSUPER.retro (Oligoengine, Seattle, WA) to generate )34 bumin. In some assays, cells were preincubated with a function-blocksiRNA and 64 SCR-pSUPER.retro. All plasmids were sequenced to ing Met mAb, clone 95309 (R & D Systems), for 1 h at 4 °C before confirm that they were correct.
plating. After incubating for 2 or 4 h at 37 'C, non-migrating cells were
To generate retroviruses, P4~ siRNA or 34 SCR-pSUPER~retro and mechanically removed from the upper chamber with a cotton swab.
expression plasmids containing envelope and packaging proteins reCells that had migrated to the lower side of the Transwell membrane quired for viral propagation (Imgenex, San Diego, CA) were transfected were fixed with 100% methanol and stained with 0.2% crystal violet in into 293T cells (3 X 10' cells/100-mm plate) with LipofectAMINE (In-2% ethanol. Invasion was quantified by counting the number of cells per vitrogen) as described by the manufacturer. Three days after transfection, viral supernatants were harvested, and SUM-159 recipient cells were infected in the presence of a serum-containing medium supple-RESULTS mented with 8 gg/mil polybrene (Sigma). Following infection for 24 h, resistant cells were selected with 4.0 jig/ml puromycin (Clontech), and
Lack of Evidence for Constitutive Association between Met
cell lines that stably expressed(34 siRNA or (34 SCR were generated. The and ae0 4 Integrin in Invasive Carcinoma Cells-Evidence to stable (34 siRNA SUM-159 cell line was then sorted by flow cytometry, support a physical association between Met and the a6e4 inteand the population of cells that expressed the lowest level of 34 was grin has been shown in co-immunoprecipitation experiments isolated. The sorting and subsequent surface labeling analysis of the grin haS beens in co-immunoprecip t exe riMet ( 4 -deficient cell line was performed with 3E1, a mouse anti-( 4 integrin using COS cells transfected to express high levels of both Met antibody (Chemicon, Temecula, CA). The decreased level of (4 expresand a6)3 4 , as well as in carcinoma cells that express both resion in this cell line was further confirmed by Western blotting with a ceptors endogenously (1) . In particular, it was reported that(34 rabbit polyclonal anti- (3 4 integrin antibody (505) (17).
immunoprecipitates of A431 cells contain significant amounts Biochemical Analyses-For the co-immunoprecipitation studies, cells of Met. To confirm these findings, we performed co-immunowere extracted for 15 min at 4 0 C with a buffer containing 50 mM Hepes precipitation assays using A431 cells, as well as MDA-MB-231 (pH 7.4), 5 mm EDTA, 2 mM EGTA, 150 mm NaCl, 10% glycerol, and 1% Nonidet P-40 in the presence of protease and phosphatase inhibitors (2 breast carcinoma cells, which express high levels of both ael4 mu phenylmethylsulfonyl fluoride, 5 mglml each of aprotinin, leupepand Met. In addition, MDA-MB-435 cells that stably express tin, pepstatin, sodium fluoride, and sodium orthovanadate). Extracts the a6e4 integrin were examined because they had been used were clarified by centrifugation at 13,000 rpm for 10 min, the superna-previously to demonstrate the necessity of a6e4 for HGF-detants were collected, and their protein concentrations were determined pendent invasion (1) . To assess a putative physical association using the Bio-Rad DC protein assay kit. Immunoprecipitations were of these two receptors, cells were extracted with the same performed with equal amounts of total protein. Extracts were preab-Nonidet P-40 (1%) buffer used previously (1) , and extracts were sorbed overnight using protein A-and G-Sepharose beads (Amersham Biosciences) to prevent nonspecific binding. After centrifugation at precleared" and then immunoprecipitated with Abs specific for 2000 rpm for 5 min to pellet these beads, the supernatants were incu-either the 34 integrin subunit (439-9B) or Met (C-12). Subsebated overnight at 4 'C with 1 jig of the following antibodies: rat p3 quently, the precipitates were analyzed by immunoblotting mAb, 439-9B (obtained from Rita Falcioni, Regina Elena Cancer Insti-with either (3 4 -specific polyclonal (505) Ab or Met Ab (C-12). As tute, Rome, Italy), polyclonal anti-human Met C-12 (Santa Cruz Bioshown in Fig. 1A exclude the possibility that the co-immunoprecipitation of For immunoblotting, cell extracts were prepared as described previ-these two receptors is dependent on the detergent used for ously. These extracts or the immune complexes were separated by extraction, we also used Triton X-100-based buffer (1%) but SDS-PAGE and transferred to Hybond-C nitrocellulose membranes failed to detect evidence for their physical association (data not (Amersham Bioscience). Membranes were blocked for 1 h using 50 mM shown). In addition, other Abs were used for the co-immunoTris buffer (pH 7.5) containing 0.15 m NaCl, 0.05% Tween 20 (TBS-T), and 5% Carnation dry milk. The membranes were incubated overnight precipitation studies in A431 cells. 034 Integrin in integrin increases the invasion of these cells toward HGF, we MDA-MB-435 Cells-To evaluate the hypothesis that the invaobserved that the mock transfectants, which lack a6134, exhibsive function of Met is dependent on the a 6 03 4 integrin, we used ited significant migration toward HGF (Fig. 3A) . Moreover, the MDA-MB-435 cells that express Met but not a 6 93 4 (Fig. 2) . In level of invasion induced by expression of a6e34 is comparable addition, the level of Met expression was increased in these with the increased invasion that results from increased Met cells by retroviral infection with a Met cDNA. This infection expression and that this latter mode of invasion occurs in the increased Met expression by -2-fold ( Fig. 2A) , but it did not absence of UA 6 3 4 (Fig. 2D) . Furthermore, expression of a 6 f3 4 in induce expression of a 6 134 (Fig. 2B) . The ability of Met to signal MDA-MB-435 cells also enhanced the ability of the MDA-MBin the absence of a 6 f3 4 expression was examined. In the control 435 cells to invade toward other chemoattractants such as cells, HGF stimulation induced a rapid and marked increase in lysophosphatidic acid, and this invasion was not inhibited by a tyrosine phosphorylation of Met as assessed by immunoprecipifunction-blocking Met antibody (Fig. 3B ). This latter result tating Met followed by immunblotting these immunoprecipiindicated that the expression of a 6 f3 4 can enhance the ability of tates with a phosphotyrosine-specific Ab (Fig. 2C) . The inten-MDA-MB-435 cells to invade independently of Met expression. sity of this phosphotyrosine signal was increased in the Met Invasion assays were performed for 4 h in serum-free medium, infectants, in agreement with the fact that these cells express and, under these conditions, no significant increase in apoptosignificantly more Met than do the control infectants ( Fig. 2A) .
sis was observed for any cell population as assessed by anSubsequently, we assessed the ability of the control and Met nexin-V fluorescein isothiocyanate staining (data not shown). infectants to invade toward HGF. Invasion assays were perTo assess the putative functional dependence of Met on the formed for 4 h without prior serum deprivation. As shown in a 6 f3 4 integrin from a different perspective, we used SUM-159 Fig. 2D , HGF induced the invasion of the control cells signifi-cells (22). These invasive breast carcinoma cells express both cantly, and this invasion was abrogated by a function-blocking a 6 134 and Met (Fig. 4A ). Using this cell line, we generated a Met-specific antibody. A 2-fold induction of HGF-dependent SUM-159 cell line deficient in P34 integrin expression using invasion was observed in the Met infectants compared with siRNA strategies (23). Stable infectants that exhibited a reduccontrol cells, substantiating the conclusion that Met promotes tion in 34 expression were sorted by fluorescence-activated cell invasion in the absence of a6P34 integrin (Fig. 2D) .
sorter using a 03 4 -specific antibody, and a population of cells a 6 93 4 Integrin Has a Generic Influence on Carcinoma Inva-was isolated that exhibited no detectable p34 expression as sion That Is Not Specific to Met-A key finding in the previous evident by immunoblotting (Fig. 4A) . Notably, the loss of 34 study, which concluded that a 6 93 4 is necessary for the invasive expression had no effect on Met expression in these cells ( ( Fig. 4B ). Loss of aU6f 4 expression reduced the ability of these The data obtained in our study unfortunately do not support the cells to invade toward HGF by -25%, but it did not abrogate central tenets of this model. Rather, our data argue that the their invasion (Fig. 4B) . Moreover, loss of a.3 4 expression also invasive function of Met can be independent of et 3 6 4 and that CL694 diminished the invasion of SUM-159 cells toward 3T3 cell-has a generic influence on the invasion of carcinoma cells that is conditioned medium by -30%.
not specific for HGF-dependent invasion. The demonstration of a physical association between an DISCUSSION integrin and a growth factor receptor provides prima facie
The report that the invasive function of the Met receptor is evidence for cooperativeness of function. For this reason, the dependent on a physical association with the a6f4 integrin, which previous finding that Met and aej4 could be co-immunoprecipiprovides a "signaling adaptor function," afforded a compelling tated from GTL-16 cells, which overexpress a constitutively model for invasive carcinoma that linked these two receptors (1) .
active form of Met, from COS cells engineered to express both receptors at high levels and from A431 cells, which also express of a constitutive association of Met with CL614 in carcinoma both receptors, strengthened the possibility of a functional cells, they do not exclude the occurrence of a transient associdependence (1). Despite using three different carcinoma cell ation between these two receptors in certain physiological sitlines that express both Met and na)4 (A431, MDA-MB-231, and uations or the possibility that a spurious association may occur MDA-MB-435, engineered to express i A ), however, we were on their gross overexpression. unable to detect any evidence for the constitutive association of
The lack of evidence for a physical association between 3604 these receptors by co-immunoprecipitation. The reason for the and Met does not negate the possibility that they exhibit funcdifference between our results and those ofTrusolino et. al. and equal amounts of protein extracts were analyzed by immunoblot analysis using Met (C-12),/34 (505), and actin-specific Abs. B, the ability of the cells described in A to invade Matrigel toward HGF (50 ng/ml) or 3T3 cell-conditioned medium was investigated in a 2-h assay. The mean number of invasive cells (± S.D.) from the five independent field per well is indicated on the y axis. Similar data were obtained in three separate experiments.
vious study was that expression of a6e 4 in MDA-MB-435 cells carcinoma invasion. The strength of the SUM-159 data, in induced their ability to invade toward HGF but not toward contrast to MDA-MB-435 cells, is that this cell line exhibits EGF. We note, however, EGF is not a suitable negative control endogenous expression of both receptors, and the assumption because MDA-MB-435 cells lack expression of the EGF recepcan made that if Met function were dependent on U 6 A 4 , it tor (24).2 Additional support for the hypothesis that the inva-should be evident in such a cell line. sive function of Met can occur independently of a, 6 4 
is provided
Based on several studies as well as the findings reported by our data on SUM-159 breast carcinoma cells. These invasive here, a consensus is emerging that a 6 /4 cooperates with growth cells express both Met and a 6 o/3, and they exhibit a robust factor receptors to promote carcinoma invasion and other funcinvasion toward HGF. Our finding that elimination of eA6 4 tions (7, 18, 25) . Perhaps the most conclusive evidence in this expression using a )3 4 -specific siRNA reduced but did not abroregard is the finding that macrophage-stimulating protein on gate invasion toward HGF, however, argues against the conbinding to its receptor, the Ron tyrosine kinase, promotes an clusion that a 6 34 is an essential adaptor for Met in promoting association between Ron and a 6 /34 that results in P13K activation and consequent migration (4) . There is also evidence that 2R. Bachelder 
13, 541-545
The mechanism that underlies the ability Of a694 to promote 14. Mercurio, A. M., Bachelder, R. E., Rabinovitz, I., O'Connor, K. L., Tani, T., and invasion likely involves its ability to stimulate P13K. Compel- Shaw, L. M. (2001) Surg. Onceol. Clin. N. Am. 10, [313] [314] [315] [316] [317] [318] [319] [320] [321] [322] [323] [324] [325] [326] [327] [328] ling evidence exists for a 6 f 4 -mediated activation of this enzyme 15. Dajee, M., Lazarov, M., Zhang, J. Y., Cai, T., Green, C. L., Russell, A. J., ymechanisms that include phosphorylation of insulin recep- (27) . In addition, the regulated ex-18. Gambaletta, D., Marchetti, A., Benedetti, L., Mercurio, A. M., Sacchi, A., and pression of specific transcription factors such as nuclear factor Falcioni, R. (2000) Introduction ca6fl4 integrin, a receptor that has been implicated in the progression of many carcinomas [7] . Double-stranded RNA triggers sequence-specific post-
The a6/P4 integrin is expressed primarily on the basal transcriptional gene silencing in a wide variety of organisms surface of most epithelia, and in a few other cell types [7, [ 1-3] . This naturally occurring process, referred to as RNA 8] . c,6/P4 is defined as an adhesion receptor for most of the interference (RNAi), has recently been established as a known laminins [9] , although increasing evidence indicates powerful technique for reducing the expression of specific that it can also signal independently of ligand binding [10, genes in mammalian systems. RNAi is induced in main -11] . The /4 extracellular domain associates exclusively with malian cells by introducing exogenous 21-nucleotide RNA the ce6 subunit to form ca6fl4 complexes [12] whereas the cU6 duplexes or small interfering RNA (siRNA) oligonucleotides subunit also associates with the /1I subunit to form c6/1 I that are homologous to the desired gene [4] [5] [6] . Because heterodimers [9] . A primary function of c6/P4 is to maintain RNAi induction offers great promise as a gene-specific the integrity of epithelia through its ability to mediate the therapeutic tool for a host of disease conditions, we invest-formation of stable and rigid structures termed hemidesmoigated whether gene silencing by siRNA oligonucleotides somes on the basal surface that link the intermediate filament could be a novel approach to inhibit the migration and in-cytoskeleton with laminins in the basement membrane [ 13] . vasion of carcinoma cells. As an initial step to addressing Although the involvement of ca6/04 in hemidesmosome this question, we utilized siRNA oligonucleotides for the organization and function has dominated the study of this ive and metastatic carcinomas and that the ca6/34 expression Materials and methods level actually correlates with the progression of these carcinomas [7] . These correlative data have been substantiated Cells by functional studies that have defined a pivotal role for a6fi4 in migration and invasion of carcinoma cells through The MDA-MB-231 human breast carcinoma cell line was its ability to interact with F-actin and activate key signal-obtained from the Lombardi Breast Cancer Depository at ing pathways [15] . Furthermore, a6fl4 promotes survival Georgetown University and maintained in low-glucose Dulin carcinoma cells lacking functional p53 protein [16] . The becco's modified Eagle's medium (DMEM, Life Technoimportance of a6/4 in survival has recently been extended logies, Rockville, Maryland) supplemented with 10% fetal by the report that a6/34 stimulates translation of vascular en-bovine serum (Sigma, St. Louis, Missouri), 100 U/ml dothelial growth factor and that this pathway is a mechanism penicillin, and 100 /xg/ml streptomycin (each from Life of survival in carcinoma cells [ 17] .
Technologies). The role of ca6/34 in migration and invasion was initially shown by exogenous expression of this integrin in siRNA transfections P4-deficient colon and breast carcinoma cells [18, 19] . In breast carcinoma studies, a6fi4 promoted invasion in a phos-Oligonucleotide sequences for fi4 integrin were desphatidylinositol 3-kinase (P13-K)-dependent manner [19] . ignated as si-/34 (GAGCUGCACGGAGUGUGUC) and Since these initial studies, a6P4 has been shown to ac-as sonv (CU gUGUGAgGCACUCA),a in vertivate P13-K and stimulate migration and invasion by both ted control. 66 integrin oligonucleotides included sigrowth factor receptor-dependent and -independent signale6 (GGUCGUGACAUUGGCUCAC) and a scrambleding mechanisms. For instance, a6/34 and ErbB-2, an orphan sequence control, si-Ser (AUGCAGAGUGGCGCUCUCU). receptor of the epidermal growth factor family, associate Oligonucleotides were synthesized by Dharmacon Research, in carcinoma cells [20] and this interaction stimulates PI3-Inc. (Lafayette, Colarodo). Cells (0.5-2.0 x 105) were K activity and invasion in a fibroblast model system [21] . plated onto 35-mm tissue culture dishes 24 h prior to trans-K ativty ndinvsio i a ibrblst ode sste [21.fection with 200 nM of siRNA duplex using 25 /.tg of An association of a6fi4 with the Met tyrosine kinase in tion with0nMf siRN duple x using 2 isg carinoa cllshasals ben dmontraed nd 6~4wasTranslT-TKO transfection reagent (Mirus, Madison, Wiscarcinom a cells h as also b een dem on strated and a6 Pl 4 w as co s n i n t e p s n e of er m a d s r b d b y h e areported to be necessary for the invasive functions of Met by consin) in the presence of serum as described by the manacting as an adapter protein to recruit PI3-K for enhanced ufacturer. One day following transfection, the transfection actng s a aaptr potin o rcrit 13-fr ehanedmedium was aspirated from the cells and replaced with Met signaling [11] . In a growth factor receptor-independent mediumpwasaspratedfrm the clls an ac dit manner, the insulin receptor substrates (IRS-1 and IRS-2) act fresh complete growth medium and incubated for an addimasner, sig inguinterediatesptor l atiated IRS-I and wiR ath P13 tional 48-72 h. For each transfection, either immunoblotting as sig n alin g in term ed iate s to lin k activ ated c16 P34 w ith P 13 -or f w y m e y w a u s d t c ni m r d c d p o e n K, a pathway that leads to an increase in carcinoma invasion or flow cytometry was used to confirm reduced protein [22] . In addition to stimulation of P13-K signaling, the 06Pi4 expression of the targeted gene. integrin has also been shown to promote migration by activation of the MAPK pathway [23, 24] , the Rac and RhoA GTPases [19, 25] , and the nuclear factor of activated T-cells Following transfection for 3-4 days, MDA-MB-231 cells family of transcription factors [26] .
were washed two times each with phosphate-buffered saline Although the data summarized above indicate that a6/4 (PBS) and HEPES buffer (20 mM HEPES, 130 mM NaCI, plays a pivotal function in the aggressive behavior of car-5 mM KCI, 0.8 MM Mg Cl 2 , 1.0 mM CaC1 2 , pH 7.45). cinoma cells, it is worth noting that this role was deduced The cells were then incubated on ice with HEPES buffer from either expression of the P4 subunit into fl4-negative containing EZ-Link Sulfo-NHS-LC-Biotin (Pierce, Rockcells or the use of antibodies to inhibit c6/34 function. In ford, Illinois) at 0.5 mg/ml for 30 min. Each dish was the current study, we used the more definitive approach of washed three times with HEPES buffer and the cells were RNAi to target the a6 and f4 subunits of the a6fi4 integ-lysed in ice-cold radioimmune precipitation (RIPA) buffer rin in breast carcinoma cells. Using this highly specific and (50 mM Tris (pH 8.0),150 mM NaCl, 10 mM EDTA, 1% efficient approach, we observed a significant reduction in Nonidet-P40, I% deoxych01ate, 0.1% SDS, 2 mM phenylthe surface expression of this integrin that correlated with oet-P40, 1% rdeoxycholate, 0.1% SDS, 2 Mpenylan inhibition of migration and invasion. Interestingly, the methylsulfony1 fid 5 4sg/ml atii weuepiland pepstatin) for 15 min at 4 0 C. Cell lysates were clarified by impact of reduced a6/34 expression was apparent on non-centrifugation at 10,000 x g for 10 min, the supernatants laminin substrates, a finding that substantiates the ligand-collected, and the total protein concentration of each lysindependent function of a6/34. These findings indicate that ate determined by the Bio-Rad DC protein assay (Hercules, inhibition of integrin expression by siRNA oligonucleotides California). may be an effective approach to assess integrin function in
Immunoprecipitations following cell surface labeling carcinoma cells, as well as to impede tumor progression in were performed with equal amounts of total protein or 60 Ag vivo.
for a3 and P 1 integrin reactions and 125-150 tg for a6 and /34 integrin samples. Lysates were preabsorbed with either rat IgG whole molecule agarose (Sigma) or, for mouse antibodies, protein G-Sepharose (Amersham, Piscataway, New Jersey) and then incubated with 1 grg of an anti-integrin overnight at 25 'C. For both chemotaxis and invasion assays, antibody overnight at 4 'C. The following antibodies were Transwell membranes were blocked on the following day used for immunoprecipitation: 439-9B, rat anti-fi4 integrin with DMEM for 1 hour at 37 'C. Cells were trypsinized and mAb (obtained from Rita Falcioni, Regina Elena Cancer resuspended in DMEM containing 0.25% heat-inactivated Institute, Rome, Italy); GoH3, rat anti-ce6 integrin mAb lipid free bovine serum albumin and a total of 1 x 105 cells (Immunotech, Westbrook, Maine); MC 13, mouse anti-P 1 was added to the upper chamber of each well. NIH3T3 conintegrin mAb (obtained from Steve Akiyama, NIH, Research ditioned medium or 100 nM lysophosphatidic acid (LPA) Triangle Park, North Carolina); P1B5, mouse anti-O3 in-(Sigma) was added to the lower chamber of each well. After tegrin mAb (Life Technologies); as well as rat and mouse incubating for 1 hour (chemotaxis assays) or 4 hours (inIgG (Sigma). Immune complexes were precipitated with rat vasion assays) at 37 'C, nonmigrating cells were removed IgG agarose or protein G-Sepharose, washed four times with from the upper chamber with a cotton swab. Cells that had RIPA buffer, and eluted in IX reducing sample buffer (bi-migrated to the lower surface of the membrane were fixed otinylated a6 and P4 integrin immunoprecipitations) or IX with 100% methanol and stained with 0.2% crystal violet in non-reducing sample buffer (biotinylated 03 and P 1 integrin 2% ethanol. Migration was quantified by counting cells per immunoprecipitations).
square millimeter using bright-field optics.
Immunoblotting Adhesion assays
For preparing whole cell lysates, cells were rinsed twice with For adhesion assays, 96-well tissue culture plates were PBS and lysed in RIPA buffer as described above. Lysates coated overnight at 4 'C with 20 jug/ml laminin-I (prepared and immune complexes were separated by SDS-PAGE and from the EHS sarcoma provided by Dr Hynda Kleinman, transferred to Hybond-C nitrocelluose membranes (Amer-NIDR, Bethesda, Maryland) or 1% BSA as a negative consham). Membranes were incubated in block buffer consist-trol. The wells were then washed 3 times with PBS and ing of Tris-buffered saline (TBS) containing 5% nonfat dry blocked for 10 min at 37 'C with 250 /g/ml heat-inactivated milk followed by antibody incubation in TBS containing lipid free BSA in DMEM. Cells (3 x 104) were resuspended 1% nonfat dry milk and 0.05% Tween-20. The blots were in DMEM and added to the protein-coated wells. After a incubated with a 1:5000 dilution of rabbit polyclonal anti-1 hour incubation at 37 'C, the wells were washed 3 times fi4-integrin (505) [15] or 0.5 Azg/ml anti-fi-actin (Sigma) with PBS, fixed for 10 min with methanol, stained with a followed by 0.04 Ag/ml peroxidase-conjugated donkey anti-solution of 0.2% crystal violet in 2% ethanol, and washed rabbit secondary antibody (Jackson Immnoresearch, West 3 times with water. The crystal violet stain was solubilized Grove, Pennsylvania). For biotinylation studies, the mem-with a 1% SDS solution and the adhesion was quantified branes were incubated in block buffer overnight and then by measuring the absorbance at 595 nm. To control for labeled with 0.2 /zg/ml peroxidase-conjugated streptavadin nonspecific adhesion, the mean absorbance (four wells per in block buffer containing 0.05% Tween-20 for 2 hours at transfection condition) of the BSA-coated wells was subtrac-25 °C. All membranes were visualized by chemilumines-ted from the mean absorbance of the laminin-coated wells cence (SuperSignal West Pico, Pierce). Densitometry was in each experiment. The BSA-corrected adhesion obtained performed using IP Lab Spectrum (Webster, New York) in the cells transfected with sequence-inverted P4 siRNA computer software. oligonucleotides was designated as equal to one and used to determine the fold induction of untransfected and P4 siRNA Apoptosis assay oligonucleotide transfected cells. Four days following transfection, cells were collected and their level of apoptosis was assessed using AnnexinVphycoerythrin (PE) (Pharmingen, San Diego, California). Results Briefly, cells were washed one time each in IX PBS and IX annexin buffer (10 mM Hepes-NaOH, pH 7.4, 140 mM siRNA oligonucleotidesfor P4 (si-fl4) decrease ax6fi4 cell NaCl, 2.5 mM CaCI 2 ) and then incubated for 15 minutes surface expression at room temperature with 5 /tg/ml AnnexinV-PE. Following We used MDA-MB-231 cells to assess the potential usefulincubation, cells were washed once with 1X annexin buffer Weus MDA-MB-231 a ells to inhibit potention in and nalyed y flw ctome~yness of RNAi as an approach to inhibit a6fl4 function in and analyzed by flow cytometry. carcinoma cells. These invasive and metastatic breast carMigration and invasion assays cinoma cells express relatively high levels of a6#l4, as well as a small population of a6p 1 (L. Shaw, personal commuFor chemotaxis assays, the upper and lower surface of the nication). The total level of endogenous PI4 subunit was remembrane in each Transwell chamber (Costar, Cambridge, duced by approximately 75% 4 days following transfection Massachusetts) were coated overnight at 4 VC with 15 /zg/ml with si-fi4 oligonucleotides compared to control invertedof collagen I (Vitrogen, Palo Alto, California). To pre-sequence oligonucleotides (si-Inv) or untransfected (Unt) pare the Transwell membranes for invasion assays, 0.5 gg cells ( Figure 1A ). Reduced fi4 expression was not detected of Matrigel (Collaborative Research, Bedford, Massachu-earlier than 96 h (data not shown) indicating that siRNA olisetts) was diluted with cold water and dried onto each filter gonucleotides directed at fP4, and possibly other membrane The ability of a6/34 to influence the functions of car-following transfection with si-34 or si-Inv oligonucleotides, cinoma cells can occur independently of ligand (laminin) cells were biotinylated, extracted in RIPA buffer, and immunoprecipitated forBý4 (B) or a6, 03, and /31 (C), and transferred to nitrocellulose. Immtnobinding [10, 11] . In particular, ca6fl4 stimulates the precipitations for a6 and /4 (150 ftg of total protein) were separated by 6% chemotactic migration of carcinoma cells on collagen I but SDS-PAGE under reducing conditions whereas U3 and /31 immunoprecipappears to have little impact on their haptotactic migra-itations (60 jg of total protein) were eluted in non-reducing sample buffer.
tion towards collagen, a process that involves only collagen The membranes were incubated with peroxidase-conjugated streptavadin.
The fold change in integrin expression following si-/34 transfection, when adhesion receptors [10] . For this reason, we assessed the the si-lnv lane is set equal to 1, is indicated. Shown are representative blots ability of MDA-MB-231 cells transfected with si-fl4 and from 3 separate experiments. si-Inv oligonucleotides to migrate towards LPA, a known or si-Inv oligonucleotides were incubated for 1 hour in laminin-I coated chemoattractant of breast carcinoma cells [10] , on collagen wells. Data are the mean fold induction (+/-SD) from three independ-I. The ligand-independent migration of MDA-MB-231 cells ent experiments, corrected for nonspecific adhesion to BSA, where the was inhibited by 45% when transfected with si-/l4 oligonuc-adhesion of si-Inv transfected cells was designated as equal to 1. The fold induction of si-/P4 transfected cells was significantly greater than obleotides compared to si-Inv oligonucleotides ( Figure 2B ). served for si-Inv transfected cells (*, two-tailed t-test, P = 0.04). (B) si-/14 Taken together, these observations confirm the importance of and si-Inv transfected MDA-MB-231 cells were biotinylated and lysed a6fi4 expression in the migration and invasion of carcinoma 96 h post-transfection and 150 jug of total protein was immunoprecipitcells as demonstrated previously by antibody inhibition ex-ated for either the /34 (top blot) or a6 (bottom blot) subunit. Immune complexes were separated by 6% SDS-PAGE under reducing conditions periments and by exogenous expression of this integrin in and transferred to nitrocellulose. The membranes were then incubated with P 4-deficient carcinoma cell lines [18, 19] . Because a6/4 can function as a receptor for laminin-1 in some cells [9] , we hypothesized that reduced a6/4 expres-sion by siRNA oligonucleotide transfection would disrupt A, adhesion to this laminin. However, the level of adhesion to si-a6 si-Scr laminin-1 in si-fl4 transfected cells was significantly higher (1.7 fold) than observed in si-Inv transfectcd cells (Figa  ure 3A) . Considering that the expression of the ca6 subunit remains unchanged in si-fl4 transfected cells ( Figure 1C and 0.39 1.0 Figure 3B ), we reasoned that the reduction of ca6fP4 might lead to redistribution of the ca6 subunit towards ca6fl 1, also a laminin-1 receptor [9] . We found that cells with decreased M* 4 fP4 expression ( Figure 3B) 
Inhibition of carcinoma invasion

6o-u6 siRNA oligonucleotides (si-o!6) inhibit invasion and migration by reducing a6#l4 cell surface expression
0 _i MDA-MB-231 cells were transfected with si-ca6 oligonuc--200. leotides and at6 scrambled-sequence oligonucleotides (siScr) to determine whether reduced a6 expression alters Pl4 cell surface levels and consequently decreases invasion and migration. Three days following transfection, cell surface si-aS sl-cr receptors were biotinylated and cell lysates were immuno-C precipitated for ca6, f4, and P1. The si-a6 oligonucleotides 600 decreased the expression of ca6 by 61% compared to cells 500 transfected with control oligonucleotides ( Figure 4A ). Interestingly, Pl4 expression was decreased by 59% in si-" 4 a6 transfected cells compared to si-Scr transfected cells * whereas the cell surface expression of PI1 was unchanged in 300 cells transfected with either si-a6 or si-Scr oligonucleotides. Isotype-control immunoprecipitations performed for each • 200 antibody were negative (data not shown). These data indic-100 ate that siRNA oligonucleotides for ca6 effectively reduce the level of ut6fl4 expression on the cell surface of breast 0 carcinoma cells. In addition, these findings substantiate the s5-06 si-Scr fact that most, if not all, P4 expressed on the cell surface is Figure 4 . si-u6 oligonucleotides decrease invasion and migration of associated with a6.
MDA-MB-231 cells. (A) Three days following transfection with si-Ce6 or
Given our finding that si-a6 oligonucleotides efficiently si-Scr oligonucleotides, MDA-MB-231 cells were biotinylated, extracted in RIPA buffer, and immunoprecipitated for a6, 34, and PI. Each immunodecrease the level of at6fl4 on the cell surface of MDA-precipitation was initiated with 125 ,g of total protein and separated by 6% MB-231 cells, we investigated the ability of si-c6 oligonuc-SDS-PAGE. The membranes were incubated with peroxidase-conjugated leotides to inhibit their invasion and migration. The invasion streptavadin. The fold change in integrin expression following si-cn6 transfection is shown in comparison to the si-Scr transfected band. (B) The of si-ct6 transfected cells through Matrigel towards LPA was ability of si-nf6 and si-Scr transfected MDA-MB-231 cells to invade Matridecreased by 53% compared to cells transfected with si-Scr gel towards LPA in a 4 h assay was assessed. The results represent the mean oligonucleotides ( Figure 4B) . In additional experiments, we number of invasive cells (+/-SD) from two wells (five fields per well). found a similar reduction in invasion when fibroblast condi-The mean number of invasive cells was significantly decreased for si-nf6 transfected cells compared to si-Scr transfected cells (* two-tailed t-test, P = tioned medium was used as the chemoattractant (data not 0.0002). Similar results were obtained in three independent trials. (C) At shown). The level of apoptosis was comparable for both 72 h post-transfection with si-cf6 or si-Scr oligonucleotides, the migration si-ce6 and si-Scr transfected cells as determined by the per-of these cells through collagen I-coated Transwell membranes towards LPA centage of AnnexinV-PE+ cells (data not shown). To assess (100 nM) for 1 h was determined. The data represent the mean number of migrating cells (+/-SD) from two wells (five fields per well). The number the ability of si-ct6 and si-Scr transfected cells to migrate in a of migrating cells was significantly less for si-cU6 transfected cells than for ligand-independent manner, we performed migration assays si-Scr transfected cells (*two-tailed t-test, P 0.001). Similar results were towards LPA on collagen I-coated Transwells. The mean obtained in two separate experiments. number of migrating cells was decreased by 39% in the siData from our laboratory and others have recently ima6 transfected cells compared to the si-Scr transfected cells plicated the /34-subunit in ligand-independent signaling. For ( Figure 4C ). These results provide more definitive evidence example, the a6/34 integrin promotes migration and invafor the ability of a6/34 to stimulate migration on non-laminin sion, as well as lamellae formation, on non-laminin substrata substrata. Overall, these data emphasize the importance of such as collagen and these functions cannot be blocked by a6/34 in the invasive phenotype of breast carcinoma cells, antibodies that inhibit a6/34 adhesive interactions, an observation that discounts the possibility of adhesion to laminins deposited by the cells [10] . More recently, it was demonDiscussion strated that a truncated form of /34 that was unable to bind laminins could promote invasion [111. In this study, the miThe relatively new technique of RNAi is a potentially power-gration of MDA-MB-231 cells on collagen I, a non-ligand ful tool to assess the contribution of specific molecules to for a6/34, was significantly inhibited by si-/34 and si-C16 invasion and metastasis. In particular, the specificity and oligonucleotides thus providing further evidence that this inefficacy of this approach may be especially valuable for tegrin can function in the absence of ligand. This concept has studying the integrin family members that exhibit complex profound implications for migration and invasion because it structures and multiple functions. To assess the feasibility implies that the ability of ca6/34 to stimulate these pathways of RNAi in this capacity, we focused on the a6/34 integrin. is not limited to specific matrix environments. Although the The involvement of this integrin in invasion and migration mechanism by which a6/34 functions in this manner is unhas been previously established by expression of the /34 known, the observation that /34 cytoplasmic domains can subunit in /34-deficient cell lines and by function blocking self-associate may explain this ligand-independent signalantibodies. In this study, we provide the first evidence that ing [30] . Furthermore, a6/34 has been shown to regulate the integrins can be inhibited by the more definite approach the function of a3/3 1, a dual collagen/laminin receptor, in of RNAi and suggest that targeting of the a6/34 integrin may keratinocytes [31, 32] . Even though we did not observe a be an effective strategy to assess the functions of this integrin change in either 03 or /31 subunit expression in our studies, and impede carcinoma progression.
we cannot rule out the possibility that c6/34 affects t3/3 IThe utilization of siRNA oligonucleotides targeted to the mediated signaling to cause decreased migration on collagen a6 and /34 subunits of the c16/34 integrin provided valuable I in si-/34 and si-a6 transfected cells. information not only for the usefulness of RNAi to inhibit Because a6/34 is an adhesion receptor for laminin-1 as surface receptors but also on the mechanistic function of this well as other laminins [9] , we hypothesized that loss of integrin. We found that the endogenous expression of a6/34 this integrin would promote a decrease in adhesion to this was not decreased until 72 or 96 hours post-transfection substrata. However, we observed an increase in adhesion with si-a6 and si-/34 oligonucleotides, respectively. This to laminin-1 following transfection with si-/34 oligonucobservation indicates that surface receptors may require con-leotides. This seeming paradox is explained by our finding siderable time for the RNAi approach to be effective and that the ax6 subunit forms additional a6/361 complexes in the suggests that the half-life of the target protein and the rate of absence of the /34 subunit. This finding is further supported surface receptor recycling are major determinants in the abil-by the observation that the a6/34 integrin is decreased with ity of RNAi to inhibit expression. In contrast, our laboratory either si-/34 or si-ix6 oligonucleotides but that cells transfechas shown that soluble proteins are inhibited efficiently by ted with si-a6 oligonucleotides have reduced levels of the RNAi, usually within 24-48 hours after transfection (R.E. /34 subunit whereas the si-/34 oligonucleotides do not sigBachelder, unpublished observation). In functional assays, nificantly decrease the expression of the U6 subunit. Thus, reduced a6/34 expression resulted in significant decreases in the a6 subunit is stabilized on the cell surface by associating invasion and migration even though the inhibition of a6/34 with /31 subunits that are found expressed in excess in many expression was less than complete. If the expression of a6/34 cells but the /34 subunit, that associates exclusively with the were further diminished, the effects would likely be more a6 subunit [12] , is lost from the cell surface when the C16 dramatic. Because the reduction in a6/34 expression in these subunit is removed. studies is dependent on both transfection efficiency and the Several groups have recently demonstrated that siRNA specific gene sequence selected for RNAi inhibition, manip-oligonucleotides can inhibit gene expression in vivo. For ulation of either of these parameters may ultimately lead to example, mouse tail vein injections with siRNA oligonucgreater reduction in a6/34 expression. For example, the use leotides for luciferase, delivered as naked siRNA oligonucof different siRNA oligonucleotides targeted to either of the leotides or as plasmid DNA, in combination with a luciferase u6/34 subunits may provide more complete inhibition. In expression vector significantly reduced luciferase expression addition, the recently developed DNA vector-based RNAi in adult mice [33] . In similar studies, the endogenous exprestechnology [27] [28] [29] which allows for stable inhibition of the sion of the green fluorescent protein was decreased in the targeted gene will eliminate transfection efficiency concerns liver of a transgenic mouse strain that expresses this gene in and should also permit the generation of a6/34 deficient cell nearly all organs [34] . Furthermore, the therapeutic potential lines. The implementation of these strategies will likely en-of this technique to inhibit cancer progression was specificable us to achieve greater reduction in a6/34 expression in ally shown by the lack of tumor formation in nude mice that future studies.
were injected with cells that had been selected for stable beta I integrins associate with ErbB-2 in human carcinoma cell lines. Introduction 10-min extension step. The sequences of amplification primers are as follows: SEMA3A Forward, GACTITGCTATCTTCCGAACTCTTGGGCAC; SEMIn addition to the classical VEGF 3 tyrosine kinase receptors, KDR A3A Reverse, GCTATACATACACACGGCTGATCCCTTG; NP1 Forward, and Flt-l, NP1 serves as a high-affinity VEGF receptor (1) . NPI ATGGAGAGGGGGCTGCCG; NP1 Reverse, CTATCGCGCTGTCGGTGexpression on endothelial cells enhances VEGF signaling by increas-TA; Plexin-Al Forward, GAGGATGCCGACATGTTCGGCTrCG; and ing the affinity of VEGF for the classical VEGF receptor tyrosine Plexin-Al Reverse, AGGGCGTCATGGGCACGCACGG. kinase KDR (1) . Interestingly, NP] expression has also been reported RNAi Transient Transfections. RNAis were designed and synthesized by in a variety of tumors in the absence of KDR or Fit-] (1, 2) . On the Dharmacon, Inc. (see below for sequences). Cells at 60% confluency were basis of the established importance of VEGF in tumor progression, transfected in penicillin/streptomycin-free medium with the indicated RNAi our previous studies investigated a role for NPI in carcinoma cells as using TKO lipid (Mirus), following the manufacturer's recommended protoa VEGF receptor, in the absence of classical VEGF receptor tyrosine col. The following RNAi concentrations were determined to be optimal for inhibiting protein expression: 200 nM RNAi for all cell lines; 200 nm SEMA3A kinases. These studies indicated that NP] supports a VEGF autocrine RNAi for MDA-231 cells; 100 nM SEMA3A RNAi for MDA-435 and MCF-7 signaling pathway that is critical for breast carcinoma cell survival (2) . cells. After 20 h, RNAis were removed, and the cells were maintained in Of note, NP] was identified originally in neurons as a receptor for complete medium with the indicated antibodies for an additional 24 h: NP] SEMA3A, a soluble member of the semaphorin family that plays a RNAi, GAGAGGUCCUGAAUGUUCCTT; Scrambled NP] control, AGAcritical role in axon guidance (3, 4) . The ability of NP], which lacks GAUGUAGUCGCUCGCUTT; SEMA3A RNAi: AAAGUUCAUUAGUGCconsensus signaling domains, to deliver SEMA3A-associated che-CCACCU; and Scrambled SEMA3A control, AAGUGCACGCCUCUAUAmorepulsive signals is dependent on NP] associations with plexins, UAUC. proteins displaying Met homologies (5, 6) . Although functions for SEMA3A and SCR SEMA3A RNAi Retrovirus Generation. To create SEMA3A-pSUPER and SCR SEMA3A-pSUPER expression vectors, the folReceived 4/9/03; revised 6/2/03; accepted 6/13/03. lowing oligonucleotides (Invitrogen, Grand Island, NY) were cloned into The costs of publication of this article were defrayed in part by the payment of page pSUPER (a gift from R. Agami, The Netherlands Cancer Institute, Amsterdam, charges. This article must therefore be hereby marked advertisement in accordance with the Netherlands): SEMA3A, 5'-gatccccAGTTCATTAGTGCCCACCTttcaag-18 U.S.C. Section 1734 solely to indicate this fact.
agaAGGTGGGCACTAATGAACTtttttggaaa-3' and 5'-agcttttccaaaaaAGTFC-'This work was supported by NtH Grants CA89209 (to A. M. M.) and CA93855 (to ATTAGTGCCCACCTtctcttgaaAGGTGGGCACTAATGAACTggg-3'; SCR SE-R. E. B.).
MA3A, 5'-gatccccGTGCACGCCTCTATATATCttcaagagaGATATATAGAG-2 To whom requests for reprints should be addressed, at Division of Cancer Biology and Angiogenesis, Department of Pathology, Beth Israel Deaconess Medical Center, GCGTGCACtttttggaaa-3' and 5'-agctttccaaaaaGTGCACGCCTCTATATATBoston, MA 02215. Phone: (617) 667-1449; Fax: (617) 667-3616; E-mail: rbacheld@ CtctcttgaaGATATATAGAGGCGTGCACggg-3'. EcoRl-and Xhol-digested incaregroup.harvard.edu.
serts containing the H1-RNA promoter and targeting oligonucleotides from pSU-3 The abbreviations used are: VEGF, vascular endothelial growth factor; NPI, PER were then subcloned into pSUPER.retro (Oligoengine, Seattle, WA). All neuropilin-l; SEMA3A, semaphorin 3A; RNAi, RNA interference; ZVAD-FMK, benzyloxycarbonyl-VAD-fluoromethyl ketone; P3-gal, 03-galactosidase; VSV, vesicuplasmids were sequenced to confirm that they were correct. lar stomatitis virus; AS, antisense.
To generate retroviruses, SEMA3A-pSUPER or SCR SEMA3A-pSUPER. retro and expression plasmids containing proteins required for viral propagasion did not impact cell survival (Fig. 1C) . Of note, this RNAi tion (Imgenex, San Diego, CA) were transfected into 293T cells. Viral superabolished NP1 expression in MDA-435 and MDA-231 cells, and it natants were harvested, and MDA-MB-435 recipient cells were infected in the increased their chemotaxis by 1.5-and 2.3-fold, respectively ( plasmid (1 jig), and either VSV-tagged, dominant-negative human plexin-Al SEMA3A inhibits axon outgrowth by binding to NPI and the (plexin-A1ACyt, provided by P. Comoglio, University of Torino, Italy) or NP1 coreceptor, plexin-A1 (5, 6) . On the basis of our finding that myc-tagged constitutively active murine plexin-Al (1 jig of PlexA1ASem, NP1 is inhibitory for breast carcinoma migration, we hypothesized provided by S. Strittmatter, Yale University School of Medicine, New Haven, that these cells express SEMA3A and plexin-Al. In fact, SEMA3A CT). The ability of these transfectants to migrate toward conditioned medium and plexin-A 1 mRNA were detected in each of three breast carciwas assessed after 48 h in the presence of ZVAD-FMK.
was ssesed fte 48 inthepresnceof ZAD-MK.noma cell lines, as well as in primary breast tumors ( Figs. 2A and Chemotaxis Assays. Chemotaxis toward conditioned NIH3T3 medium was assessed using collagen (Cohesion; 15 jig/ml)-coated Transwell chambers, 3A). We also identified SEMA3A and plexin-A1 protein by imas described previously (8) .
munoblotting proteins extracted from these samples with a SEMA3A-or plexin-Al-specific antibody ( Figs. 2A and 3A) . To Results and Discussion elucidate a function for SEMA3A in breast carcinoma cells, we
Given that NP1 is expressed in breast carcinoma cell lines (Refs. 1 reduced SEMA3A expression using a SEMA3A RNAi This RNAi, and 2; Fig. IA) and tumors (Fig. IA) , we assessed the potential which reduced SEMA3A expression significantly (Fig. 2B) , ininvolvement of this receptor in carcinoma chemotaxis. Surprisingly, a creased the migration of these cells (Fig. 2B) without influencing NPl-neutralizing antibody increased the chemotaxis of MDA-231 cell survival (data not shown). To assess the importance of cells toward NIH 3T3 conditioned medium 2-fold (Fig. 1B) . To plexin-Al in migration, MDA-231 cells were transfected with a confirm and extend this finding, we implemented an RNAi strategy to plexin-A1 cytoplasmic domain deletion mutant that inhibits diminish NP1 expression in each of three breast carcinoma cell lines. SEMA3A signaling (6) . Expression of this mutant in MDA-231 Our previous data indicate that NP1 is essential for breast carcinoma cells enhanced their migration significantly (Fig. 3B) . Conversely, survival because it supports VEGF autocrine survival signaling (2) . expression of a semaphorin homology domain deletion mutant of To evaluate the role of NP1 in migration separately from its require-plexin-Al that exhibits constitutive activity in neurons (9) inhibment for breast carcinoma cell survival (2) , NPI RNAi transfections ited MDA-231 migration (Fig. 3C) . None of these reagents influwere performed in the presence of the general caspase inhibitor, enced cell survival in the presence of ZVAD-FMK (Fig. 3, B and ZVAD-FMK. Under these conditions, the inhibition of NP1 expres-C). These data indicate that an autocrine pathway involving 5231 15-h (MDA-435), or 3-h (MDA-231) assay.
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RNAi SEMA3A, NP1, and plexin-A 1 impedes the chemotaxis of breast recombinant VEGF and recombinant SEMA3A, which exhibit similar carcinoma cells. Our ability to increase breast carcinoma migration affinities for NP1 and NPl/plexin complexes, respectively (1, 5) , to by expressing a dominant-negative plexin-Al suggests that other compete for NP1 binding (15, 16) . On the basis of these findings, we plexins, if expressed in these cells, cannot support SEMA3A postulated that endogenous VEGF and SEMA3A compete for NP1 signaling in the absence of plexin-Al function, binding, and that the ratio of the concentration of these proteins in Genes that are inhibitory for cell growth are frequently subject to carcinoma cells is a critical determinant of their chemotactic rate. To chromosomal deletion, mutational inactivation, or gene silencing in determine this ratio, we measured the relative amounts of SEMA3A tumor cells (10) (11) (12) . The ability of breast carcinoma cells to migrate and VEGF protein in these cells (Fig. 4A) . We then compared the ratio and invade, despite their expression of molecules involved in of these concentrations to the relative chemotactic rate of these SEMA3A signaling, suggested that they support a novel mechanism carcinoma cells. As shown in Fig. 4B , MCF-7 cells, which exhibited for repressing SEMA3A function. Increased VEGF expression is a the lowest chemotactic rate, displayed the highest ratio of SEMA3A hallmark of breast carcinoma progression (13, 14) . Until recently, the to VEGF protein. MDA-435 cells, which were more chemotactic than function of VEGF in tumor progression was thought to relate solely to MCF-7 cells, demonstrated a lower SEMA3A:VEGF concentration its angiogenic activity. We were intrigued by the reported ability of ratio (Fig. 4B) ?. 9 Cells Cells -RT +RT Fig. 3 . Plexin-AI signaling inhibits chemotaxis. A: top panel, plexin-A I-specific RT-PCR reactions were performed using the indicated mRNAs; middle panel, plexin-AI and Statl proteins were detected by immunoblotting (rat anti-plexin-A I provided by H. Fujisawa, Nagoya University Graduate School of Science, Nagoya, Japan; rabbit anti-Statl provided by Santa Cruz Biotechnology); bottom panel plexin-AI fragments were amplified from cDNA isolated from carcinoma cells purified from breast tumors. B, MDA-231 cells were cotransfected with a P3-gal-expressing plasmid in addition to either a control plasmid or a VSV-tagged plexin-Al cytoplasmic domain deletion mutant (plexin-AIACyt), and their migration was measured after 48 h by 5-bromo-4-chloro-3-indolyl-43-o-galactopyranoside staining. Expression of the VSV-tagged constrnct was confirmed by immunoblotting with a VSV-specific antibody (Sigma). C, MDA-231 cells were cotransfected with a P-gal-expressing vector and either a control plasmid or a constitutively active, myc-tagged plexin-Al construct (plexin-AlASem). The number of migrated cells after 48 h was assessed by 5-bromo-4-chloro-3-indolyl-13-D-galactopyranoside staining. Expression of the myc-tagged construct was confirmed by immunoblotting with a myc-specific antibody (Sigma). For B and C, the mean number (bars, ±SD) of migrated cells from two wells (four fields/well), as well as the percentage of apoptotic cells, is indicated. *, P < 0.02 in a Student's t test. Similar results were obtained in two trials.
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MDA-435 cells were infected with retroviruses expressing either a SEMA3A-specific or scrambled RNAi (control). Stable infectants that A.
MCF MDA MDA expressed SEMA3A RNAi exhibited a significant decrease in (Fig. 4D) . These infectants were then transfected transiently .starl 2' • with either the VEGF AS or control oligonucleotide. Confirming the Neuropilin is a semaphorin HI receptor. Cell, 90: 753-762, 1997 . the mean number of cells (bars, +SD) that had migrated toward conditioned medium in 5. Takahashi, T., Fournier, A., Nakamura, F., Wang, L., Murakami, Y., Kalb, R. G., a 16-h assay. Similar trends were observed in three trials. C, MDA-435 cells were Fujisawa, H., and Strittmatter, S. M. Plexin-neuropilin-I complexes form functional transfected with either a VEGF AS or sense (Control) oligonucleotide as described semaphorin-3A receptors. Cell, 99: 59-69, 1999. previously (Ref. 2; + ZVAD-FMK) , and their migration toward conditioned medium was 6. Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G., Song, H., Chedotal, A., assessed in a 15-h assay. The percentage of apoptotic cells was measured as described for Winberg, M. L., Goodman, C. S., Poo, M., Tessier-Lavigne, M., and Comoglio, P. M. Fig. 1 . D, MDA-435 cells were infected stably with either a SEMA3A RNAi-expressing Plexins are a large family of receptors for transmembrane, secreted, and GPIor control retrovirms. These retroviral cells were then transfected transiently with either a anchored semaphorins in vertebrates. Cell, 99: 71-80, 1999 . control or VEGF AS oligonucleotide (+ ZVAD-FMK). The ability of these cells to 7. Miao, H., Lee, P., Lin, H., Soker, S., and Klagsbrun, M. Neuropilin-I expression by migrate toward conditioned medium was determined in a 15-h assay. For C and D, the tumor cells promotes tumor angiogenesis and progression. FASEB J., 14: 2532 14: -2539 show that this c6134-dependent regulation of VEGF translathat the a6P34 integrin enhances vascular endothelial tion plays an important role in the survival of metastatic growth factor (VEGF) translation in breast carcinoma cells, breast carcinoma cells by sustaining a VEGF autocrine The mechanism involves the ability of this integrin to signaling pathway that involves activation of PI-3K and stimulate the phosphorylation and inactivation of 4E-binding Akt. These findings reveal that integrin-mediated activation protein (4E-BP1), a translational repressor that inhibits the of PI-3K-Akt is amplified by integrin-stimulated VEGF exfunction of eukaryotic translation initiation factor 4E (elF-4E).
pression and they provide a mechanism that substantiates 0.
The results described above prompted us to investigate the A Benedetti and Harris, 1999; McKendrick et al., 1999) . elF-T I 4E plays a critical role in the recruitment of the translational machinery to the 5' end of mRNA, which is demarcated by
an m7GpppN cap (where m is a methyl group and N is any nucleotide) (Raught and Gingras, 1999) . The m7 cap is es-C sential for the translation of most mRNAs including VEGF VEG-F (De Benedetti and Harris, 1999; Raught and Gingras, 0 1999 ). Dissociation of 4E-BP1 from eIF-4E enables eIF-4E
A-,in to initiate translation (Gingras et al., 1999 (Gingras et al., , 2001b . The reg-CL ulation of 4E-BP1 phosphorylation by t6P34 derives from s The ability of the cr6134 integrin to promote the survival Results were obtained from three independent experiments. Apoptosis of carcinoma cells is VEGF dependent was minimal in the presence of 10% FBS (unpublished data).
C.
int-c(B) Mock-transfected clone 6D7 and P4 integrin-(clone 1, 3A7;
To examine the hypothesis that the ability of the ot6134 inteclone 2, 5B3) expressing MDA-MB-435 subclones were transiently grin to promote survival is VEGF dependent, we used transfected with VEGF sense or antisense oligonucleotides and MDA-MB-435 cells, which lack expression of this integrin. maintained in low serum (0.5% FBS) medium. After 24 h, the level Stable expression of oL6I34 in these cells enhances their abilof apoptosis in these cells was assessed as described above. The ity to survive in stressful conditions (Bachelder et al., data are presented as the mean difference (± SD) in annexin positivity between mock-transfected and c66p4-expressing MDA-MB-435 1999b). Importantly, however, expression of ot6P 34 does not cells. Similar results were observed in two separate experiments. alter the expression of other integrin subunits in these cells (C) The relative amount of VEGF protein in extracts obtained from and does not influence their adhesion to matrix (Shaw et al., the MDA-MB-435/44 cells transfected with either the VEGF sense 1997). As shown in Fig.1 A, a significant level of apoptosis (S) or antisense (AS) oligonucleotide was determined by immunowas observed after 24 h of serum deprivation in the parental blotting using a polyclonal anti-VEGF immune serum.
MDA-MB-435 cells and mock transfectants, as well as in transfectants that express ot613 4 containing a cytoplasmic 1 C). As shown in Fig. 1 B, this reduction in VEGF expresdomain deletion of the 34 subunit that lacks the ability to sion abrogated the survival-enhancing effect of ct6134 under signal (Shaw et al., 1997) . Stable subclones that express the conditions of serum deprivation. intact cr6134 integrin, however, were protected from apoptosis under these conditions. Based on these results and our
The cr6134 integrin increases VEGF protein but not previous finding that the survival of metastatic breast carcimRNA expression noma cells is dependent on VEGF, we used a VEGF antiGiven that the survival effect of ot 6 13 4 expression is VEGF sense oligonucleotide to reduce VEGF expression in the dependent, the novel possibility arose that VEGF expression MDA-MB-435/p34 transfectants and assessed the impact of could be regulated by this integrin. VEGF expression can be reducing VEGF expression on their survival (Fig. 1, B and regulated at the level of both transcription and mRNA sta-C). The VEGF antisense oligonucleotide reduced VEGF bility (Nabors et al., 2001; von Marschall et al., 2001 ), protein expression significantly in the P34 transfectants (Fig. mechanisms that would alter the steady-state levels of VEGF Integrin (t6134) regulation of VEGF and carcinoma survival I Chung et al. 167 A transfectants, or cells that express a cytoplasmic domain deletion of the 134 subunit (134-ACYT) (Fig. 2 B) . These resuits indicate that the ot6134 integrin regulates VEGF pro-S1 r tein expression. It is also worth noting that the level of Z apoptosis observed in these populations in response to serum deprivation correlates inversely with their expression of 0's-VEGF ( Fig. 1 A and Fig. 2 B) .
To substantiate the regulation of VEGF expression by Si6134, integrin-specific antibodies were used to cluster either -o6134 or o5131 and the effects of integrin-mediated cluster- ot6134 is influencing VEGF translation.
To obtain more definitive evidence that ot613 4 is regulat- Figure 2 . Expression of the e6134 integrin increases VEGF protein ing VEGF translation, we performed polysome analysis of
1.
but not steady-state mRNA. (A) The amount of VEGF mRNA in the VEGF message. mRNA isolated from the MDA-MBextracts obtained from mock-(clone 1, 6D2; clone 2, 6D7) and P34 b integrin-(clone 1, 3A7; clone 2, 5B3) transfected MDA-MB-435 4 subclones was quantified by real-time PCR. The data are presented gradient (Fig. 3 A) and the relative amount of VEGF mRNA o as the mean ratio of VEGF to 3-actin mRNA (±-SD) obtained from in each fraction was determined by real-time PCR (Fig. 3 B) . In the MDA-MB-435/134 transfectants, VEGF mRNA fracin low serum (0.5% FBS) medium for 24 h. Extracts of these cells o containing equivalent amounts of protein were analyzed for their tionated in the heavy polysomal region, whereas in the mock relative expression of VEGF and actin by immunoblotting. Similar transfectants, the majority of VEGF mRNA was associated results were observed in four independent experiments. (C) Mock with light polysomal to ribosomal subunit fractions. This re-(clone 6D7) and 34 integrin-expressing (clone 3A7) MDA-MB-435 sult indicates that the translation of VEGF in the MDAsubclones were maintained in low serum (0.5% FBS) medium for 24 h.
MB-435/P34 transfectants is cap dependent. These cells were detached with trypsin and incubated with integrinspecific antibodies ((x6 integrin, 2B7; P34 integrin, A9; a5 integrin, Sam!) or IgG for 30 min in suspension and allowed to adhere on Identification of an ei6134 integrin-mediated signaling anti-lgG-coated plates for 60 min before lysis. In addition, cells pathway that regulates VEGF expression were preincubated in cycloheximide (CHX) at a concentration of 10 Our finding that ot613 4 regulates the cap-dependent transla-[Lg/ml for 30 min and then incubated with either the a6 or 34 tion of VEGF prompted us to assess the ability of this inteintegrin antibodies in the presence of cycloheximide. Extracts of these cells containing equivalent amounts of protein were analyzed grin to stimulate the activity of the eIF-4E translation initiafor their relative expression of VEGF and actin by immunoblotting. tion factor. The ox6134 integrin is a potent activator of the Similar results were observed in two independent experiments. PI-3K-Akt signaling pathway in MDA-MB-435 and other carcinoma cells (Shaw et al., 1997; Bachelder et al., 1999a; Gambaletta et al., 2000; Hintermann mRNA . In addition, regulation can also occur at the level of et al., 2001) , and this pathway has been linked to the regula-VEGF translation (Kevil et al., 1996; Akiri et al., 1998;  tion of protein translation. Specifically, the serine/threonine Stein et al., 1998). As shown in Fig. 2 A, 6D7) and 134 (clone 3A7) transfectants were maintained in low serum (0.5% FBS) medium for 24 h. These cells were detached with sessed the steady-state phosphorylation levels of 4E-BP1 and trypsin and incubated with integrin-specific antibodies (0.6 integrin, S6 kinase (p 7 0S1K), which are both downstream targets of 2B7; n6 integrin, GOH3; ca5 integrin, Sam1; 34 integrin, A9) or IgG for 30 min as described in the legend to Fig. 2 . The phosphorylation mTOR, in cells that had been serum deprived for 24 h. Instatus of 4E-BP1 (Ser 65), S6K (Thr 389), and Akt (Ser 473) was deed, a marked increase in the level of phosphorylation of assessed in extracts from these cells using phosphospecific antibodies. 4E-BP1 (on Ser65) and p 7 0 s6K (on Thr389) was evident in Similar results were observed in four independent experiments. the MDA-MB-435/134 transfectants relative to either the mock transfectants or the parental cells (Fig. 4 A) . Phosphorproximately twofold. These results, together with the polysome ylation of Ser65 of 4E-BPl has been shown to be critical for analysis data (Fig. 3) , indicate that ot6[34 regulates VEGF exdissociation of 4E-BP from eIF-4E (Gingras et al., 200 1a) .
pression by eIF-4E-mediated, cap-dependent translation. The reduced expression of 4E-BP1 in the 34 transfectants
To confirm the specificity of the ct6P34 integrin in mTOR compared with the mock transfectants that is apparent in signaling, the effects of integrin-mediated clustering on 4E- Fig. 4 A may reflect the possibility that the 4E-BP Ab does BP1 phosphorylation were assessed. A substantial induction not recognize the hyperphosphorylated form of the protein of Akt, 4E-BP1, and p 7 0 s16K phosphorylation was observed as well as it recognizes the hypophosphorylated form.
upon cu6P34 integrin clustering in the P34 transfectants but The involvement of eIF-4E in VEGF translation was connot in the mock transfectants (Fig. 4 C) . In contrast, clusterfirmed by the expression of an antisense eIF-4E oligonucleing of the a513 1 integrin did not stimulate phosphorylation otide in the MDA-MB-435/134 transfectants. As shown in Fig. of these molecules in either the mock or 134 transfectants.
B, expression of this oligonucleotide reduced the level of
Collectively, these data demonistrate the preferential ability VEGF protein significantly. In contrast, expression of the fullof the oc6134 integrin to regulate the mTOR signaling pathlength eIF-4E cDNA increased the VEGF protein level by apway and, more importantly, the phosphorylation of4E-BP1. -RPA LI mutant transfectants (clone El h) were maintained in low serum (0.5% FBS) for 24 h. Extracts from these cells were analyzed by 0. Figure 5 . Stimulation of 4E-BP1 phosphorylation, VEGF expression, immunoblotting to assess the relative expression of VEGF and F- Identification of a specific tyrosine residue in the 34
To establish that PI-3K and mTOR are required for 4E-cytoplasmic domain required for o•6P4 stimulation of BP1 phosphorylation and VEGF expression, we performed 4E-BP1 phosphorylation and VEGF expression the antibody clustering experiments in the presence of the Recently, a critical tyrosine residue (Y1494) was identified PI-3K-specific inhibitor LY294002 and the mTOR-specific in the third fibronectin type III repeat of the 34 cytoplasmic inhibitor rapamycin (Fig. 5) . As shown in Fig. 5 A, both of domain, and this tyrosine was shown to be essential for actithese inhibitors blocked the ot634-mediated induction of vation of PI-3K by ot6P34 (Shaw, 2001) . To assess the im-4E-BPI phosphorylation and VEGF expression. Although portance of Y1494 in 4E-BP1 phosphorylation and VEGF rapamycin did not block Akt phosphorylation, LY294002 expression, stable subclones of MDA-MB-435 cells were did inhibit its phosphorylation, confirming that Akt acts upgenerated that expressed ut6P34 containing a Y1494F mutastream of mTOR and downstream of PI-3K (Fig. 5 A) .
tion. As shown in Fig. 6 A, VEGF protein expression was These inhibitors did not block the phosphorylation of barely detectable in these transfectants compared with the ERKI and ERK2 (Fig. 5 A) .
wild-type transfectants. Also, the steady-state level of 4E-Finally, we investigated the importance of the mTOR BP1 phosphorylation was substantially lower in the Y1494F pathway in survival, using rapamycin and LY294002. As mutant transfectants than in the wild-type 34 transfectants.
shown in Fig. 5 B, rapamycin treatment increased the apopInterestingly, these mutant transfectants also exhibited an ,,--eightfold higher level of apoptosis than the wild-type 134 0.. transfectants in response to serum deprivation (Fig. 6 B) .
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The apoptosis of the mutant cells was reduced substantially Figure 8 . ce614 regulates 4E-BP1 phosphorylation, VEGo by the addition of recombinant VEGF (Fig. 6 B) , a result expression, and survival in carcinoma cells that express this for the P4 integrin (si-P4) or the corresponding inverted sequence o (si-inv). After 72 h, the cells were placed in medium containing low Er The hypothesis that activation of Akt is a major determinant serum (0.5% FBS) for an additional 24 h and then extracted. Extracts for the stimulation of 4E-BP1 phosphorylation and VEGF of these cells were immunoblotted as described in the legend to expression was assessed by expressing a constitutively active Fig. 4 to assess expression of 34 integrin, VEGF, and actin, as well g Akt construct in MDA-MB-435 cells that are deficient in as the phosphorylation of 4E-BP1. Similar results were observed in ox6134 signaling. For this purpose, we used MDA-MB-435/ three independent trials. (C) Apoptosis was assessed in the same mock transfectants that lack u6034 expression and the populations of cells and is reported as the percentage of annexin V-FITC-positive, P1-negative cells. The data shown are mean values MDA-MB-435/P34 Y1494F transfectants, described above, (± SD) of three independent experiments performed in triplicate. which are deficient in ot6134-mediated activation of PI-3K.
(D) MDA-MB-231 cells were maintained in low serum (0.5% FBS) These cells were infected with adenoviruses that encoded eimedium for 24 h and harvested by trypsin treatment. The suspended ther a myristoylated Akt (Myr-Akt) construct or 13-galactosicells were incubated with integrin-specific antibodies (34 integrin, dase as a control. As shown in Fig. 7 , expression of Myr-Akt A9; a6 integrin, 21B7; a5 integrin, Sami) or IgG for 30 min in suspension and allowed to adhere on anti-IgG-coated plates for 30 stimulated 4E-BP1 phosphorylation and VEGF expression min. Extracts of these cells were immunoblotted with phosphospecific substantially in both populations of transfectants in comparantibodies to assess the relative phosphorylation of Akt and 4E-BP1, ison to cells that expressed [3- galactosidase. This result indias well as with antibodies specific for VEGF and actin. Similar cates the critical importance of Akt activation by t6134 for results were obtained in five experiments. stimulating VEGF expression.
tegrins (Plopper et al., 1998; Mukhopadhyay et al., 1999;  a6134 regulates 4E-BP1 phosphorylation, VEGF Saad et al., 2000) . Initially, we confirmed that the survival of expression, and survival in carcinoma cells that express these cells is dependent on their expression of VEGF. As this integrin endogenously shown in Fig. 8 A, expression of a VEGF antisense oligonuGiven that the data reported above are based on the exogecleotide in these cells (Bachelder et al., 2001) resulted in an nous expression of u6P34 in a6034-deficient carcinoma cells, approximate fourfold increase in annexin V staining upon we sought to extend our findings to cells that express this inserum starvation compared with either untreated cells or tegrin endogenously, a pattern that is typical of most carcicells that expressed the sense oligonucleotide. noma cells. For this purpose, we used MDA-MB-231 breast To establish a role for u6134 in regulating VEGF exprescarcinoma cells because they express the ux6134 and 56131 insion and survival rigorously, we used a small interfering
